期刊
CURRENT HYPERTENSION REPORTS
卷 18, 期 8, 页码 -出版社
SPRINGER
DOI: 10.1007/s11906-016-0674-1
关键词
Antihypertensive medication; Cognitive decline; Dementia; Alzheimer's disease
资金
- National Institute of Health Research
- Imperial College, London
- National Institute for Health Research [PDF-2012-05-197] Funding Source: researchfish
- National Institutes of Health Research (NIHR) [PDF-2012-05-197] Funding Source: National Institutes of Health Research (NIHR)
Purpose of review There is an established association between hypertension and increased risk of poor cognitive performance and dementia including Alzheimer's disease; however, associations between antihypertensive medications (AHMs) and dementia risk are less consistent. An increased interest in AHM has resulted in expanding publications; however, none of the recent reviews are comprehensive. Our extensive review includes 15 observational and randomized controlled trials (RCTs) published over the last 5 years, assessing the relationship between AHM and cognitive impairment. Recent findings All classes of AHM showed similar result patterns in human studies with the majority of study results reporting point estimates below one and only a small number of studies (N = 15) reporting statistically significant results in favor of a specific class. Summary Only a small number of studies reported statistically significant results in favor of a specific class of AHM. Methodological limitations of the studies prevent definitive conclusions. Further work is now needed to evaluate the class of AHM and cognitive outcomes in future RCTs, with a particular focus on the drugs with the promising results in both animals and human observational studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据